Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,227,009 | $7,234,370 | $5,357,599 | $4,291,269 |
| - Cash | $242,077 | $399,266 | $276,472 | $869,191 |
| + Debt | $1,416,569 | $1,453,539 | $1,369,195 | $1,251,050 |
| Enterprise Value | $6,401,501 | $8,288,643 | $6,450,322 | $4,673,128 |
| Revenue | $705,138 | $787,647 | $587,367 | $810,456 |
| % Growth | -10.5% | 34.1% | -27.5% | – |
| Gross Profit | $693,923 | $778,514 | $573,251 | $799,614 |
| % Margin | 98.4% | 98.8% | 97.6% | 98.7% |
| EBITDA | -$353,721 | -$235,870 | -$227,758 | -$5,188 |
| % Margin | -50.2% | -29.9% | -38.8% | -0.6% |
| Net Income | -$453,897 | -$366,286 | -$269,722 | -$28,597 |
| % Margin | -64.4% | -46.5% | -45.9% | -3.5% |
| EPS Diluted | -3.04 | -2.56 | -1.9 | -0.2 |
| % Growth | -18.8% | -34.7% | -850% | – |
| Operating Cash Flow | -$500,947 | -$307,513 | -$274,370 | $30,799 |
| Capital Expenditures | -$45,280 | -$28,011 | -$20,099 | -$17,901 |
| Free Cash Flow | -$546,227 | -$335,524 | -$294,469 | $12,898 |